Literature DB >> 8280611

Abnormal erythrocyte band 4.1 protein in myelodysplastic syndrome with elliptocytosis.

H Ideguchi1, Y Yamada, S Kondo, K Tamura, S Makino, N Hamasaki.   

Abstract

A case of myelodysplastic syndrome with haemolytic anaemia and a marked elliptocytosis is reported. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) of erythrocyte membrane proteins revealed that the patient's band 4.1 was decreased to about 50-70% of that of control and contained abnormal molecule migrating in a faster mobility than normal band 4.1, which was confirmed by immunoblotting. The actin/spectrin ratio of the patient's ghosts diminished to about 70% of that of control ghosts. Flowcytometric analysis showed that the glycophorin C content of the patient's erythrocytes was reduced but maintained the level of about 70% of that of normal, indicating that the glycophorin C-band 4.1 interaction might not be so seriously damaged as to cause elliptocytic shape change. We postulate that the abnormal band 4.1 produced from the abnormal erythroid clone may be the primary molecular defect and result in a dysregulation of spectrin-actin interaction to cause erythrocyte shape change and membrane instability.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280611     DOI: 10.1111/j.1365-2141.1993.tb03183.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Posttranslational Modifications of Red Blood Cell Ghost Proteins as "Signatures" for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients.

Authors:  Klara Pecankova; Pavel Majek; Jaroslav Cermak; Jan E Dyr
Journal:  Turk J Haematol       Date:  2016-09-09       Impact factor: 1.831

2.  Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia.

Authors:  Jacob D Kjelland; Denis M Dwyre; Brian A Jonas
Journal:  Case Rep Hematol       Date:  2017-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.